Daniel Hétu, MD, MBA
DIRECTOR
Dr. Daniel Hétu, MD, MBA, brings over 20 years of experience in investment banking, corporate development, and licensing within the life sciences sector. He has been instrumental in guiding companies at all stages of development across North America and internationally. Known for his strategic thinking and problem-solving skills, Dr. Hétu has a proven track record of managing complex initiatives, projects, and transactions. His investment focus is on building companies in the therapeutics and medical device sectors, aiming to develop products and technologies that have a meaningful impact on patient care. Dr. Hétu currently manages Lumira Ventures' Montreal office.
An accomplished senior executive with deep expertise in financing and corporate business development, Dr. Hétu spent 10 years at Shire Pharmaceuticals and Biochem Pharma (prior to its acquisition by Shire). As Vice President of Business Development (North America) and Vice President of Corporate Development, he led multiple financing, licensing, and M&A transactions in the therapeutics, vaccine, and diagnostics sectors. At Biochem, Dr. Hétu also served on the company's portfolio committee and the steering committee for strategic research collaborations, in addition to holding board positions with several portfolio companies.
Before joining Biochem Pharma, Dr. Hétu worked as an investment banker at a leading Canadian investment bank, where he was involved in mergers, acquisitions, and financing transactions across various industrial sectors.